|
|
||||||||
,1



* INRA, UMR1080, Dairy Production, F-35590 Saint-Gilles, France
Agrocampus Ouest, UMR1080, Dairy Production, F-35000 Rennes, France
Dairy and Swine Research and Development Centre, Agriculture and Agri-Food Canada, STN Lennoxville, Sherbrooke, QC, Canada, J1M 1Z3
Veterinary Physiology, Vetsuisse Faculty, University of Bern, CH-3012 Bern, Switzerland
1 Corresponding author: Sophie.Lemosquet{at}rennes.inra.fr
| ABSTRACT |
|---|
|
|
|---|
Key Words: dairy cow glucose metabolism propionic acid amino acid
| INTRODUCTION |
|---|
|
|
|---|
Meta-analyses and modeling approaches tried to estimate end products of digestion and to predict whole-body glucose availability in ruminants with the objective to improve current feeding systems based on energy value of feed (Bermingham et al., 2008). However, in lactating dairy cows, only a few experiments have studied the effects of individual macronutrients infused in the digestive tract on the whole-body glucose rate of appearance (Ra) or the splanchnic release of glucose, and even fewer experiments have compared the effects of 2 macronutrients (Clark et al., 1977; Lemosquet et al., 2004a). Direct supply of glucose (Glc) through postruminal infusions (Clark et al., 1977; Rigout et al., 2002; Lemosquet et al., 2004a) or starch (Reynolds, 2006) increases or tends to increase Ra or post-liver flow of glucose. However, C3 provided as infusions or in feed for ruminants does not cause a clear-cut increase in Ra or in hepatic glucose release (review by Kristensen, 2005). In dairy cows, rumen C3 infusion increased Ra to a lesser extent than did postruminal isoenergetic infusion of Glc (Lemosquet et al., 2004a). Also, postruminal infusions of casein were found to significantly or numerically increase Ra in lactating dairy cows (Clark et al., 1977; König et al., 1984). Two studies have compared postruminal Glc and casein infusions in lactating ruminants. Only numerical effects of treatments were observed on Ra in cows (Clark et al., 1977), whereas in goats Ra was increased only by casein (Ranawana and Kellaway, 1977).
In lactating dairy cows, mammary uptake of water and, consequently, milk yield greatly depends on mammary lactose synthesis through osmotic regulation. Because glucose is the main precursor for lactose synthesis, an increase in posthepatic glucose availability could be a potential regulator of milk yield. Indeed, Danfaer (1994) reported a linear relationship between whole body glucose flux rate and milk yield. In lactating cows receiving diets providing almost no intestinal starch (grass silage), an increase in Ra was suggested to be the key factor in increasing milk and lactose yields (Rigout et al., 2002, 2003). However, an isoenergetic comparison of the effect of C3 and Glc on Ra and milk yield (Lemosquet et al., 2004a) did not provide clear evidence of whether the increase in Ra was the key mechanism, because at the highest dose infused the Glc treatment increased Ra more than C3 did, whereas both nutrients only tended to increase milk yield. In addition, casein infusions increased milk yield but Glc infusions did not, although they had a similar effect on Ra (Clark et al., 1977). The effect of casein on Ra has generally been attributed to the supply of glucogenic AA, mainly nonessential AA (NEAA), but infusion of the NEAA fraction of casein did not increase milk yield (Kim et al., 2000).
Taken together, these findings raise the issue of the relationship between whole-body glucose availability and lactose yield, that is, whether lactose synthesis is driven by whole-body glucose availability or whole-body glucose availability is driven by lactose synthesis. The hypothesis of increased lactose synthesis in response to increased glucose Ra should be examined in a single experiment concomitantly studying the effect of several glucogenic nutrients. The aim of the experiment described herein was therefore to quantify the efficiency of isoenergetic infusions of Glc, C3, and NEAA in terms of increasing Ra and to analyze if lactose synthesis was driven by glucose Ra.
| MATERIALS AND METHODS |
|---|
|
|
|---|
The cows were fed the same basal diet throughout the study. The diet was based on grass silage and concentrate was formulated to limit the amount of intestinal starch to by pass starch from wheat and barley contained in concentrate (Table 1). The same diet was fed to all the cows. It consisted of the following on a dry matter (DM) basis: 56.3% grass silage, 29.6% energetic concentrate (Table 1), 12.1% formaldehyde-treated soybean meal and 2% mineral and vitamin premix. The intestinal starch was estimated to correspond to 15 g/kg DM of total diet (grass silage+concentrate) using the equations of Offner et al. (2003) and Offner and Sauvant (2004) and feed content of starch published in Sauvant et al. (2004). The 4 treatments (Table 2) consisted of continuous infusions of 1) water in the control (Ctrl); 2) Glc into the duodenum; 3) C3 into the rumen; and 4) a mixture of 5 NEAA (NEAAm; Ala, Asp, Glu, Gly, and Ser) into the duodenum. Infusions were formulated to provide the same amount (5.15 ± 0.05 Mcal/d) of digestible energy (DE): the nutrients infused were supplemented on an iso-DE basis relative to a negative control (diet) to distinguish between the effect of DE supply and the effect of the type of nutrients. The NEAAm was composed of the 5 most oxidized AA described in ruminants (Black et al., 1990) administered in a proportion similar to that in casein, except for Asp because of its low solubility. Cows were individually fed a restricted diet providing 88% of their net energy requirements (INRA, 1989). Therefore, the combination of diet plus infusions provided approximately 100% of net energy requirements. The diet was formulated to provide 122% of protein requirements (INRA, 1989) expressed as protein digestible in the intestine (PDI) so as to avoid any limiting effect of protein supply on endogenous glucose production and on milk and protein yields.
|
|
The first 2 d of each period included a transition for the infusions (the cows received 33% of the total subsequent infusion on d 1, and 66% on d 2). Solutions were infused continuously using peristaltic pumps. Details of infusions are given in Table 2. All the cows in all treatments received a similar volume of water (Table 2) in the rumen (about 48.3 kg) and in the duodenum (about 20.3 kg). Buffers (NaHCO3 and KHCO3) were infused into the rumen to limit the ruminal pH decrease and avoid acidosis with C3 treatment (Table 2). The same solution was infused into the rumen during Ctrl and Glc treatments to maintain the anion-cation balance constant between treatments (i.e., Na+ infused at 6.2 ± 0.21 mol/d and K+ infused at 2.7 ± 0.10 mol/d). In the NEAAm treatment, because Glu was infused as GluNaH2O, providing Na+ by infusion, KHCO3 was added to the duodenal infusion. (Table 2)
Measurements, Sampling, and Analyses
Measurements were made on the last 7 d of each 14-d period. The amounts of feed offered and feed refusals were measured daily. The DM content of grass silage was determined daily to permit adjustment of the amount offered. Ruminal fluid was assayed for pH and for VFA and ammonia concentrations in samples taken at 0730, 1130, and 1530 h on d 11. The pH was measured immediately. Ammonia and VFA samples were prepared, frozen, and analyzed as described by Rigout et al. (2003). Samples for VFA analysis were pooled.
Milk yield was recorded, and fat and protein contents were determined by infrared analysis (Milkoscan, Foss Electric, Hillerød, Denmark) at each milking. On d 13 at the morning milking, 100 mL of milk was taken for chemical analyses. Milk samples were used to analyze total N, true protein N, and casein (Kjeldahl), lactose and glucose concentrations (spectrophotometry), milk fatty acid (gas chromatography with butyl esters), according to the methods described by Hurtaud et al. (2000). Briefly, analysis of total N was immediately performed on milk samples stored at 4°C. Milk samples were deproteinized and filtrated before to be frozen at –20°C for analyses of true protein N (precipitation at pH 4.6 with TCA) and of casein (precipitation at pH 4.6 with 10% acetic acid and 1 M sodium acetate) and for analysis of glucose (with HClO4: vol/vol). Analysis of milk fatty acids was performed on milk samples stored at – 20°C.
The effect of the treatments on Ra was measured on d 12 between 1315 h and 1530 h. A solution of [6,6-2H2]glucose, 99 mol% excess (mpe; Cambridge Isotope Laboratories, Andover, MA) was prepared with sterile saline for the priming dose injection and infusion (302 ± 2.2 mmol/L) and was sterilized by filtration through a 0.22-µm sterile disk filter (Millipore, Saint-Quentin en Yvelines, France). The priming dose was injected into one jugular vein (13 mmol) and the solution was continuously infused at a constant rate of 23.56 mmol/h for 120 min with a syringe pump (Harvard Apparatus, Les Ulis, France). To check whether blood glucose coefficients of variation were less than 5%, 1 mL of blood was taken every 10 min (from 20 min before to 80 min after the beginning of the infusion) from the other jugular vein catheter so that a rapid measurement of blood glucose concentration could be made using a glucometer (LifeScan One Touch, Johnson & Johnson Co., Milpitas, CA). In addition, blood samples were collected with syringes (S-Monovette, 7.5 mL; Sarstedt, Nümbrecht, Germany) containing heparin (12 to 30 IU/mL) 15 and 10 min before injection of [6,6-2H2]glucose solution, to measure natural abundance, as well as during the plateau period, at 80, 90, 100, and 110 min after the priming injection/start of the infusion. Blood was centrifuged at 2,500 x g for 10 min at 4°C. Plasma samples to be analyzed for glucose concentration were stored at –20°C. Plasma samples for the measurement of [6,6-2H2]glucose enrichments were deproteinized with an equal volume of 1.2 M perchloric acid and filtered before being stored at –20°C. Preparation of samples before gas chromatography/mass spectrometry analysis to determine [6,6-2H2]glucose enrichments was as described by Lemosquet et al. (2004b). Derivatization was performed with butaneboronic acid followed by addition of acetic anhydride. The isotopic enrichments of glucose, expressed as mpe above preinfusion values, were quantified for m/z ions 297 and 299 in triplicate by gas chromatography/mass spectrometry in electron impact ionization mode (GC 8060 chromatograph coupled to a VG Platform II, Fisons Instruments, Altrincham, UK). A control plasma at 3.73 mpe was introduced in each batch of analysis (every 10 samples) with an inter-day coefficient of variation of 2.8%.
On d 11 of each period, 6 jugular blood samples were taken every 2 h, beginning at 0700 h, for all metabolites, with additional samples taken every h (n = 12) for growth hormone (GH) determinations. Samples were collected in syringes containing heparin (S-Monovette, 7.5 mL; Sarstedt) for BHBA, glucose, lactate, total glycerol, NEFA, and urea analyses. Samples for insulin, GH, IGF-1, and cortisol determinations were collected in syringes containing 1.2 to 2 mg/mL of K2-EDTA (S-Monovette, 7.5 mL; Sarstedt). Syringes containing K2-EDTA (S-Monovette, 2.5 mL; Sarstedt) and 260 µL of the protease inhibitor aprotinine (2,600 KIU in sterile saline at 8.5 mg/mL of NaCl; Antagosan, Hoechst Marion Roussel GmbH, Marbourg, Germany) were used to collect blood for determination of glucagon concentrations. Blood samples were centrifuged at 2,500 x g for 10 min at 4°C. For AA analyses, plasma was deproteinized with 50% vol/vol sulfosalicylic acid and supernatant collected after centrifugation at 2,000 x g for 15 min. Plasma was also deproteinized with 50% (vol/vol) perchloric perchloric acid, followed by filtration to analyze acetate, BHBA, and lactate. All samples were stored at –20°C until analysis, except for samples for hormone analysis, which were stored at –80°C.
Samples for analysis of AA, acetate, BHBA, lactate, and total glycerol were pooled per cow and per period before the analyses. Plasma-free AA were analyzed by chromatography on a cationic exchange resin column, ion exchange chromatography followed by ninhydrin reaction (Hurtaud et al., 2000) on a Biotronik LC 3000 (Biotronik GmbH, Maintal, Germany). Other plasma metabolites were measured on a multiparameter analyzer (Kone Instruments Corp., Espoo, Finland) using the following procedures. Acetate was analyzed using the acetyl-CoA synthase, citrate synthase, and malate dehydrogenase method (Sigma-Aldrich, Saint-Quentin Fallavier, France). Concentrations of BHBA were analyzed using BHBA dehydrogenase (Sigma-Aldrich). Enzymatic kits were used for glucose (hexokinase, GLUC HK 07 3672, Roche Diagnostics, Meylan, France), for L-lactate (lactate oxidase and peroxidase; Lactate-PAP 61192, BioMérieux S.A., Marcy lEtoile, France), for NEFA (acetyl-CoA synthase, acyl-CoA oxidase and peroxidase; NEFA C Wako kit, Oxoid S.A., Dardilly, France), for total glycerol (lipase, glycerol kinase, glycerol-3-P oxidase and peroxidase, GPO PAP, Biotrol, Earth City, MO), and for urea (urease and glutamate dehydrogenase, Urée UV cinétique; Kone Diagnostics, Evry, France).
Insulin, GH, and IGF-1 were analyzed by RIA as described by Lemosquet et al. (2004a). Glucagon was analyzed using a RIA kit (Cliniscience, Linco Research, St. Charles, MO) and cortisol by the EIA method (Negrao and Marnet, 2006).
Calculations and Statistical Analyses
Whole-body glucose Ra was determined with the following equation, assuming steady-state:
|
|
The mean values obtained for each cow per period were used in the statistical analyses. Each parameter was analyzed using PROC MIXED of SAS (2004) according to the following statistical model: Yijk = µ + COWi + PERIODj + TREATMENTk + eijk with COW considered as a fixed effect. Results were expressed as least square means with standard errors of means. Differences among treatments were compared using 3 orthogonal contrasts. The first contrast was used to test the effect of infusions (control vs. infusions: –3 Ctrl, 1 Glc, 1 C3, 1 NEAAm). The second contrast was used to compare the effect of duodenal Glc and ruminal C3 with the effect of infused NEAAm (1 Glc, 1 C3, –2 NEAAm). The third contrast was used to compare the effect of Glc with that of C3 (1 Glc and –1 C3). Statistical significance was set at P
0.05 and tendency at 0.05 < P
0.10.
| RESULTS |
|---|
|
|
|---|
|
|
Infusions of the 3 nutrients increased (P = 0.03) total VFA concentrations in the rumen (Table 5) but only C3 changed the molar proportion of VFA, mainly by increasing the percentage of ruminal propionic acid and decreasing the percentage of ruminal acetic acid. The infusion of NEAAm increased the ammonia concentration in the rumen and produced a lower rumen pH, probably because no buffer was infused into the rumen.
|
|
Energy Metabolites and Hormone Concentrations
During the day of the metabolite measurements (Table 7), plasma glucose concentration tended (P = 0.09) to increase with the infusions of nutrients because it tended (P = 0.08) to be higher during Glc and C3 compared with NEAAm. Although not as strong, these variations were similar to those observed during the infusion of [6,6-2H2]glucose. Plasma lactate concentration greatly increased (P < 0.001) in NEAAm compared with Glc and C3.
|
Plasma insulin concentrations were not affected by any of the treatments, whereas plasma glucagon concentrations increased (P < 0.01) during NEAAm compared with Glc and C3 infusions. Plasma concentrations of cortisol and GH were not affected by any of the treatments either. Plasma concentrations of IGF-1 increased with the infusions but were not affected by the type of nutrients infused.
Milk Fatty Acid Composition
Infusions of the 3 nutrients decreased (P < 0.01) the yield of short fatty acids (sum of C4 to C8; Table 8), with the decrease being larger (P < 0.01) for Glc and C3 than for NEAAm for the yield of short fatty acids. The yield of medium-chain fatty acids (i.e., sum of C10 to C14) was not affected by nutrient infusions, but tended (P = 0.06) to be higher during Glc compared with C3. The yield of the sum of C16:1 and C16:0 increased, on average, with the infusions (+32 g/d). It was linked to a higher yield in NEAAm (contrast Glc and C3 vs. NEAAm: –42.5 g/d; P < 0.01) and in Glc compared with C3 (+30 g/d; P = 0.05). In contrast, the yield of all C18 were reduced with Glc and C3 compared with NEAAm. The yield of the sum of odd fatty acids increased during the C3 treatment (contrast Glc and C3 vs. NEAAm at P = 0.09 and contrast Glc vs. C3 at P < 0.01: +6.8 g/d).
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Increase in Ra with DE Supply Depends on the Type of Nutrients
This increase in total DE supply (diet plus infusion) with the infusions of nutrients led to an increase in Ra. Expressed per Mcal of total DE supplies, the Ra obtained for the Ctrl treatment was similar (0.23 mmol/Mcal of DE, Table 6) to that previously reported in a review of dietary treatments (Wieghart et al., 1986). However, the type of nutrients had an effect on the Ra response, and infusions of Glc led to the highest Ra (+745 mmol/h) and to a significantly higher ratio of Ra to total DE supply (0.324 mol/Mcal of total DE). The increase in Ra corresponded to 0.76, 0.33, and 0.32 of maximal glucose equivalent for Glc, C3, and NEAAm infusions, respectively (Table 2). This order was in accordance with reports in the literature comparing C3 with Glc (Seal and Parker, 1994; Lemosquet et al., 2004a). Infusions of glucogenic nutrients led to a higher increase in Ra compared with a single increment in DE. Increasing DE intake through diet also led to an increase in nongluconeogenic end products of digestion such as acetate or butyrate.
The increment in glucose Ra relative to Glc infusions (0.76) was slightly higher but fell within the same range as those obtained in previous experiments (0.54 and 0.60; Rigout et al., 2002; Lemosquet et al., 2004a) with similar doses of duodenally infused Glc. However, in these previous experiments, Glc treatments (diet plus infusion) were compared with isocaloric treatments, with the substitution of energy probably leading to a decrease in the availability of other glucose precursors. A ratio lower than the unity could be explained by glucose utilization by the small intestine during absorption or by a decreased endogenous glucose production (Lemosquet et al., 2004a; Reynolds, 2006).
The increment in Ra obtained with C3 infusion only represented 0.33 of the maximal increment that could obtained if all infused C3 were used in gluconeogenesis (Table 2). This is in a range similar to the efficiency (0.4 of C3 carbons infused) observed in steers by Veenhuizen et al. (1988), despite a small reduction in DMI in the current study which could have limited the Ra increase. In ruminants, this ratio varies between 0.1 and 0.76 (Lemosquet et al., 2004a), and in dairy cows, when C3 was infused in isoenergetic substitution for a VFA mixture, this ratio was about 0.28 (Lemosquet et al., 2004a). The extra supply of C3, however, did not always increase hepatic glucose release or Ra (see review by Kristensen, 2005). One explanation for this is that increased portal C3 supply will be lower than rumen C3 supply, however portal C3 recovery of rumen irreversible loss varied (0.51 to 0.95) between experiment (Seal and Parker, 1994; Kristensen, 2005). At the liver, C3 can also substitute for other glucose precursors, which limits the increase in total gluconeogenesis (Seal and Parker, 1994). Another explanation could relate to increased C3 oxidation with a higher supply (Veenhuizen et al., 1988).
The increment in Ra obtained with NEAAm represented about 0.32 of the increase that could be expected if all of the infused AA were used in gluconeogenesis (Table 2) calculated with the Van Milgen model (2002). However, like C3 infusion, NEAAm reduced DMI, therefore decreasing gluconeogenesis resulting from dietary intake. The increase in Ra observed in response to NEAAm infusion was lower than the increment usually obtained with casein infusions. When expressed in mol of C in glucose per mol of infused C, the increment in Ra corresponded of 0.23 (Table 2) of carbons infused as NEAAm (Table 2) and ranged from 0.14 to 0.89 of carbons infused as casein, with most values falling between 0.31 and 0.42 (Clark et al., 1977; König et al., 1984). Infusions of the most oxidized AA in the NEAAm mixture (Black et al., 1990) did not induce a higher Ra response than casein, which is a mixture of EAA and NEAA; however, from a biochemical standpoint, all AA are glucogenic except Leu and Lys (Wolff et al., 1972). The plasma concentrations of Asp, Glu, Ala, and Gly increased between 2.3- and 4.6-fold with NEAAm infusions relative to Glc and C3 infusions, whereas the plasma concentration of Ser increased 16.5-fold compared with Glc and C3, pointing to significant differences in the utilization of these AA in particular to the different intestinal metabolism of NEAA infused, leading to a different NEAA profile in the portal vein (Doepel et al., 2007 ; Hanigan et al., 2004). In sheep, Ala and Glu accounted for 5.5 and 3.4% of Glc turnover, whereas Gly, Ser, and Asp accounted for less than 1% (Wolff et al., 1972), which suggests that NEAAm was probably not the most efficient AA mixture for increasing Ra.
The NEAAm infusion increased plasma lactate and glucagon concentrations. The increment in lactate concentration probably resulted from extra lactate synthesis associated with Ala supplied in NEAAm. The glucagon concentration usually increases in response to AA infusion (Weekes et al., 2006) in ruminants, a trend that has been linked to increased hepatic uptake of AA and both stimulated glycogenolysis and gluconeogenesis (Brockman and Laarveld, 1986; Hippen et al., 1999) and hepatic oxidation of propionic acid (Gill et al., 1985). The increment observed in this study is quite high compared with the increments observed with AA mixtures (Weekes et al., 2006).
The rather low Ra values obtained with C3 and NEAAm could also be explained by the fact that gluconeogenesis efficiency could be driven by mammary demand of glucose. In the present experiment lactose yield was not increased which could have limit the Ra increase. Increasing glucose demand through the administration of phlorizin has been shown to increase Ra without an additional supply of precursor (Veenhuizen et al., 1988; Amaral-Phillips et al., 1993). In that scope, casein infusions increased milk yield (Clark et al., 1977) and increased Ra (Clark et al., 1977) more than NEAAm on the basis of carbon ratio (as discussed before).
No Direct Link Between Ra and Yields of Milk and Lactose
In the present experiment, Glc and C3 infusions increased glucose Ra but barely increased milk and lactose yields. Moreover, lactose yield with NEAAm infusion was lower than with the Ctrl treatment. Therefore, glucose availability appears not to have been a factor driving milk yield. This was observed even though a grass silage-based diet was fed to limit the supply of intestinal starch, so that the study was conducted under conditions in which glucose availability could be the main limiting factor, as reported in previous studies (Hurtaud et al., 2000; Rigout et al., 2002, 2003).
Similar infusions of C3 were already reported to barely increase milk yield (Raggio et al., 2006b). However, the absence of a significant increase in milk yield associated with Glc infusions in the present experiment seems surprising in light of the findings presented in the review by Rigout et al. (2003). One difference in this study compared with earlier investigations is that Glc was infused in large amounts and used to supplement diet (+12% of DMI), thereby increasing total energy supply (+3 Mcal of NEL) and decreasing the protein-to-energy-supply ratio. This stands in contrast with previous studies, in which proportional increases in lactose yield and Ra were observed (Rigout et al., 2002) in response to Glc infusions (0 to 5.3 mol/d). Because in the present experiment Glc was infused in supplement to the diet, an increase in total energy supply might have shifted glucose partitioning toward tissues other than the mammary gland, even though only plasma concentrations of IGF-1 increased, but not plasma insulin. However, an increase of muscle and adipose tissues sensitivity to insulin could not be excluded with Glc treatments (Lemosquet et al., 2002). In other studies, however, glucose and casein infusions that were provided to supplement diet increased or tended to increase glucose Ra, but only casein infusions increased milk yield (Clark et al., 1977; Ranawana and Kellaway, 1977). In addition, the inefficiency of NEAA in increasing milk yield has been reported (Kim et al., 2000) but EAA fraction of casein increased milk yield (Kim et al., 2000). All of these observations suggest that even in a grass silage-based diet, whole body glucose availability is not always the limiting factor for lactose synthesis, which could depend on the equilibrium between EAA supply and whole-body glucose availability.
Ratio of Lactose Production to Ra Decreased with Increased Ra
As in previous investigations (Rigout et al., 2002; Lemosquet et al., 2004a), as Ra increased, the ratio of lactose yield to Ra decreased. Glucose treatments exhibited the lowest ratios of lactose yield to Ra in the present experiment as well as in Lemosquet et al. (2004a). The decrease in glucose utilization for lactose synthesis may occur at several levels. First, glucose partitioning could change, favoring glucose utilization in tissues other than the mammary gland through increased glucose availability, including turnover of the glycogen pool. Second, part of the change in glucose utilization can also occur within the mammary gland. Important adjustments probably occurred in mammary gland metabolism because glucose levels in milk did not simply follow the trend in Ra or lactose. Mammary glucose uptake exceeds the requirements for lactose synthesis, and the excess glucose could increase and be used in metabolic pathways other than lactose synthesis when glucose availability is high. In the present experiment, these questions remain unanswered because mammary uptake of nutrients was not measured. The different modifications observed in milk composition and in plasma metabolites in the comparision of Glc and C3 with NEAAm suggest that both mechanisms were probably involved.
Other Effects of Infusions on Milk Composition and Links to Metabolism
Several of the parameters measured suggest that both mammary metabolism (increase in fatty acid elongation) and extra mammary metabolism (decrease in C18 fatty acid in milk and in BCAA concentration) were modified by Glc infusions and, to a lesser extent, by C3 infusions as previously observed (Rigout et al., 2002, 2003).
At the whole body level, the large dose of infused NEAAm probably greatly increased ureagenesis because the plasma urea concentration increased by 70%. At the mammary gland level, the reduction of protein yield with NEAAm could be explained by a decrease of mammary uptake of AA from group 1 (Raggio et al., 2006a) because plasma concentration of AA in group 1 was decreased. Milk fat yield, the C18 yield, and plasma NEFA were higher in NEAAm compared with Glc and C3, and held steady at a level similar to the Ctrl. All of these responses suggesting fat precursor mobilization are in accordance with the negative net energy balance observed in NEAAm and Ctrl. However, the milk fat yield increased with NEAAm, mainly because the C16 fatty acid yield increased. It remains difficult to interpret this change of metabolism because C16 fatty acids are partly synthesized within the mammary gland and partly taken up directly from the blood supply.
| CONCLUSIONS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
Received for publication August 6, 2008. Accepted for publication February 23, 2009.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Lemosquet, G. Raggio, G. E. Lobley, H. Rulquin, J. Guinard-Flament, and H. Lapierre Whole-body glucose metabolism and mammary energetic nutrient metabolism in lactating dairy cows receiving digestive infusions of casein and propionic acid J Dairy Sci, December 1, 2009; 92(12): 6068 - 6082. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |